HCA Healthcare, Inc. (HCA) Stock Analysis
Healthcare · Medical Care Facilities · NYSE
HCA Healthcare, Inc. (HCA) posted $75.60B in revenue for fiscal 2025 (up 7.1% year over year), at a 9.0% net margin, and has compounded revenue about 8.0%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on HCA Healthcare, Inc.
HCA Healthcare, Inc. has grown revenue from $41.49B to $75.60B over the last 10 fiscal years, compounding about 8% a year. The most recent year was up 7.1%, roughly in line with its longer-run pace.
Net margin sits at 9%, up 0.8 points year over year. It carries about $49.17B of total debt.
At today's valuation the market is pricing in roughly -0.1% annual free-cash-flow growth — versus the 3.8% it actually delivered over the last five years, so the price is arguably undemanding against what it has already proven.
Synthesised from HCA Healthcare, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
HCA Healthcare, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.49B | $43.61B | $46.68B | $51.34B | $51.53B | $58.75B | $60.23B | $64.97B | $70.60B | $75.60B |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | $2.89B | $2.22B | $3.79B | $3.50B | $3.75B | $6.96B | $5.64B | $5.24B | $5.76B | $6.78B |
| Net margin | 7.0% | 5.1% | 8.1% | 6.8% | 7.3% | 11.8% | 9.4% | 8.1% | 8.2% | 9.0% |
Source: HCA Healthcare, Inc. SEC filings (10-K). 17 years of history available in the interactive view.
HCA Healthcare, Inc.: no obvious red flags in the filings
Our deterministic scan of the filed statements — receivables vs sales, earnings vs cash, dilution, leverage and margins — didn't flag anything. Ask about the risks →
What growth is priced into HCA stock?
At today's market cap of $87.16B, HCA Healthcare, Inc. is priced for free-cash-flow growth of about -0.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $7.69B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 3.8%/yr over the last five fiscal years and revenue 8%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 17 years of HCA Healthcare, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track HCA in your portfolio →
HCA Healthcare, Inc. financial history by metric
Compare HCA Healthcare, Inc. with peers
About HCA Healthcare, Inc.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Healthcare, Inc. — frequently asked questions
What is HCA Healthcare, Inc.'s revenue?
HCA Healthcare, Inc. (HCA) reported revenue of $75.60B for fiscal year 2025, up 7.1% from the prior year, according to its SEC filings.
Is HCA Healthcare, Inc. profitable?
Yes. HCA earned net income of $6.78B in fiscal 2025, a net margin of 9.0%.
What is HCA's P/E ratio?
HCA Healthcare, Inc. trades at a price-to-earnings ratio of about 13.5 based on the latest data in our nightly-refreshed cache.
How fast is HCA Healthcare, Inc. growing?
HCA's revenue grew at roughly 8.0% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does HCA Healthcare, Inc. have?
As of fiscal year 2025, HCA carried roughly $49.17B in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is HCA Healthcare, Inc.'s market cap?
HCA Healthcare, Inc. (HCA) has a market capitalization of about $87.16B, based on the latest data in our nightly-refreshed cache.
When does HCA Healthcare, Inc.'s fiscal year end?
HCA's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into HCA stock?
At today's market cap of $87.16B, HCA Healthcare, Inc. is priced for free-cash-flow growth of about -0.1% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $7.69B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 3.8%/yr over the last five fiscal years and revenue 8%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from HCA Healthcare, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.